News tagged with oncology group
Children with cancer have complete responses in a Children's Oncology Group phase 1 trial
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
Cancer
May 17, 2012 |
not rated yet |
0
Problems in cancer care are not uncommon
Cancer care is increasingly complex, and as many as one in five cancer patients may experience "breakdowns" in their care, according to a new study in the Journal of Clinical Oncology. Such breakdowns include communication proble ...
Cancer
Apr 18, 2012 |
not rated yet |
0
Study: Preoperative estrogen-blocking therapy may preempt need for mastectomy
Preoperative treatment with aromatase inhibitors increases the likelihood that postmenopausal women with estrogen receptor-positive breast cancer will be able to have breast-conserving surgery rather than a mastectomy, according ...
Cancer
Mar 23, 2012 |
5 / 5 (1) |
0
Study reports steady increases in long-term survival among children with acute lymphoblastic leukemia
A study by the Children's Oncology Group (COG) reported that five-year survival for acute lymphoblastic leukemia (ALL, the most common type of pediatric cancer) among children treated through COG clinical trials increased ...
Cancer
Mar 12, 2012 |
5 / 5 (2) |
0
Vandetanib doesn't up survival in non-small-cell lung cancer
(HealthDay) -- Vandetanib does not improve overall survival for patients who have received previous treatment for advanced non-small-cell lung cancer (NSCLC), according to a study published online Feb. 27 ...
Cancer
Mar 02, 2012 |
not rated yet |
0
Inherited risk factors for childhood leukemia are more common in Hispanic patients
Hispanic children are more likely than those from other racial and ethnic backgrounds to be diagnosed with acute lymphoblastic leukemia (ALL) and are more likely to die of their disease. Work led by St. Jude Children's Research ...
Cancer
Jan 30, 2012 |
5 / 5 (1) |
0
Studies help clarify the role of lapatinib and trastuzumab in treating HER2 positive breast cancer
In patients with HER2-positive breast cancer, Tykerb (lapatinib) has been used both in combination with herceptin (trastuzumab) and as an alternative single-agent therapy for pre-surgery (neo-adjuvant) chemotherapy treatment. ...
Cancer
Jan 16, 2012 |
5 / 5 (2) |
0
|
Research suggests that lipofilling may be safe during conservation treatment for breast cancer
A new study has gone some way to answering the question about whether or not a technique called lipofilling is safe for women who are having their breasts reconstructed after surgery for breast cancer.
Cancer
May 25, 2011 |
not rated yet |
0
- Pages: 1 2
